Skip to content

A clinical study of low molecular weight heparin in improving pregnancy outcomes in women with repeated implant failure in freeze-thaw embryo transfer cycles

A clinical study of low molecular weight heparin in improving pregnancy outcomes in women with repeated implant failure in freeze-thaw embryo transfer cycles

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083577
Enrollment
Unknown
Registered
2024-04-28
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent implantation failure in frozen embryo transfer cycles

Interventions

experimental group:luteal support therapy+ LMWH
control group:luteal support therapy

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 40 Years

Inclusion criteria

Inclusion criteria: (1) Age = 40 years when the oocytes were retrieved (2) Planning for FET after IVF or ICSI cycles (3) The participants have at least one good-quality frozen blastocyst and will transfer only one frozen blastocyst. The blastocyst should be from day 5 or day 6 and have a Gardner morphology score = 4 BC. (4) Participants with a history of at least 3 failed fresh/frozen high-quality embryo transfer cycles . (5) Participants are willing to cooperate with the research plan and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) One of the couples has chromosomal abnormalities. (2) Untreated submucosal uterine fibroids or endometrial polyps (3) History of autoimmune diseases, eg antiphospholipid syndrome (APS), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and so on. (4) Thin endometrium (< 7 mm) before transfer (5) Medical contraindications to LMWH or ART and/or pregnancy (6) Women who are currently receiving any anticoagulant drugs, such as aspirin. (7) History of intrauterine adhesions (8) Untreated hydrosalpinx visible via ultrasound (9) Embryos planned for thawing and transfer are from cryopreserved oocyte sources or have undergone secondary cryopreservation (10) History of recurrent spontaneous abortion (RSA) (11) FET after preimplantation genetic testing(PGT)

Design outcomes

Primary

MeasureTime frame
live birth rate;

Secondary

MeasureTime frame
clinical pregnancy rate;biochemical pregnancy rate;embryo implantation rate;early miscarriage rate;ongoing pregnancy rate;ectopic pregnancy rate;pregnancy-related complications;perinatal complications;fetal birth weight;congenital malformations;other adverse reactions;

Countries

China

Contacts

Public ContactCui Linlin

The Second Hospital of Shandong University

fdclear3@126.com+86 156 2879 6080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026